Active in New York
Chris Ryall is a Director at Finsbury. Chris joined Finsbury’s London office in 2012, moving to the New York office in 2014. He specializes in advising clients on all aspects of financial communications, with a particular focus on high profile transactions. Prior to joining Finsbury Chris worked for Anglo American, first in Corporate Finance and then managing strategic communications for the Group’s divestment program. His transactional experience includes the proposed merger of Praxair and Linde Group, Takeda’s acquisition of ARIAD Pharmaceuticals, the sale of SABMiller to AB InBev, Lanxess’ acquisition of Chemtura, the merger of Holcim and Lafarge, Ahold’s merger with Delhaize, Ball Corporation’s acquisition of Rexam plc and Sorin Group’s merger with Cyberonics. Chris holds a Bachelor of Business Science degree from the University of Cape Town, South Africa.